Metoclopramida Medinfar

Metoclopramide, the active ingredient in Metoclopramida Medinfar, is a dopamine antagonist presented as an oral dosage form for oral use. It is employed to treat nausea and vomiting, gastroparesis, gastro‑esophageal reflux disease, and postoperative nausea and vomiting in adult patients.

GNH USA supplies Metoclopramida Medinfar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Its supply chain supports timely delivery and traceability across multiple continents.

Metoclopramide acts on the dopaminergic pathways that regulate nausea, vomiting and gastrointestinal motility.

Nausea and vomiting: reduces frequency and severity of acute and chronic nausea episodes. Gastroparesis: enhances gastric emptying and alleviates related symptoms. Gastro‑esophageal reflux disease (GERD): improves lower esophageal sphincter tone and reduces reflux episodes. Post‑operative nausea and vomiting: prevents nausea and vomiting after surgical procedures.

Metoclopramide may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness - Fatigue - Diarrhea - Headache

Serious or Rare Side Effects: - Extrapyramidal reactions (e.g., dystonia, akathisia) - Tardive dyskinesia with prolonged use - Neuroleptic malignant syndrome - Severe allergic reactions (anaphylaxis)

When prescribing Metoclopramide, clinicians should consider several safety precautions to minimize risk.

- Assess renal function: adjust dose or avoid use in severe impairment. - Monitor for extrapyramidal symptoms: watch for involuntary movements and discontinue if they occur. - Evaluate for depression or suicidal thoughts: discontinue if severe mood changes develop. - Use with caution in gastrointestinal obstruction: may exacerbate blockage. - Avoid in known hypersensitivity: discontinue at first sign of allergic reaction. - Store at room temperature: keep in the original packaging, protect from moisture.

Metoclopramide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive central dopamine blockade increasing extrapyramidal risk. - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase metoclopramide plasma levels.

Moderate Interactions (Monitor Closely): - Anticholinergics: may reduce prokinetic effect. - SSRIs: potential for serotonin syndrome when combined. - Diuretics: may affect electrolyte balance and gastric motility.